Entrada Therapeutics, Inc.
← Back to TRDA Overview

Entrada Therapeutics, Inc. (TRDA)

Revenue & Top-Line Growth

Latest Revenue

$875K

Financial Fundamentals

TRDAQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2026-03-310.00B-32.6%-95.7%0.01B-96.7%
2025-12-310.00B-19.5%-96.5%0.03B-87.9%
2025-09-300.00B-17.2%-91.8%0.06B-71.4%
2025-06-300.00B-90.5%-97.9%0.08B-66.8%
2025-03-310.02B-45.0%-65.2%0.17B+5.7%
2024-12-310.04B+91.1%-10.6%0.21B+63.4%
2024-09-300.02B-79.3%-55.3%0.22B+146.9%
2024-06-300.09B+60.2%+421.2%0.24B+451.2%
2024-03-310.06B+41.3%+134.0%0.16B+544.8%
2023-12-310.04B-4.3%0.13B
2023-09-300.04B+140.7%0.09B
2023-06-300.02B-28.1%0.04B
2023-03-310.03B0.03B
2022-12-310.00B0.00B
2022-09-300.00B0.00B
2022-06-300.00B0.00B
2022-03-310.00B0.00B
2021-12-310.00B0.00B
2021-09-300.00B0.00B
2021-06-300.00B0.00B
2021-03-310.00B0.00B
2020-12-310.00B0.00B
2020-09-300.00B0.00B
2020-06-300.00B0.00B
2020-03-310.00B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20250.03B-87.9%
20240.21B+63.4%
20230.13B
20220.00B
20210.00B
20200.00B
20190.00B